NAT1 and breast cancer: Based on the data presented here and the current literature on NAT1 KO in breast cancer cells, we believe that mitochondrial function is reduced by NAT1 KO and further that the fate of glucose is altered, resulting in less glucose flux through the TCA/Krebs cycle.